Location History:
- Postfach, GB (1998)
- West Hamsteaad, GB (1998)
- London, GB (1996 - 2008)
- West Hampsted, GB (2008)
- West Hampstead, GB (2009)
- Villanova, PA (US) (2005 - 2012)
Company Filing History:
2 out of 1,248 
2 out of 949 
2 out of 202 
Years Active: 1996-2012
Title: Mary M Bendig: Innovator in Therapeutic Antibodies
Introduction
Mary M Bendig is a prominent inventor based in London, GB. She has made significant contributions to the field of therapeutic antibodies, holding a total of 13 patents. Her work focuses on innovative methods for treating various medical conditions through the use of humanized immunoglobulins.
Latest Patents
Among her latest patents is a method for inhibiting alpha-4-dependent interactions with VCAM-1 using anti-VLA-4 antibodies. This invention provides methods of treatment for a range of conditions, including asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, and acute leukocyte-mediated lung injury. Another notable patent is a reshaped human antibody to the human interleukin-6 receptor. This antibody is designed to be less immunogenic to humans, making it promising for therapeutic uses.
Career Highlights
Mary has worked with notable companies such as Merck Patent Gesellschaft mit beschränkter Haftung and Chugai Seiyaku Kabushiki Kaisha. Her experience in these organizations has contributed to her expertise in the development of therapeutic antibodies.
Collaborations
Throughout her career, Mary has collaborated with esteemed colleagues, including Jose William Saldanha and S Tarran Jones. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Mary M Bendig is a trailblazer in the development of therapeutic antibodies, with a strong portfolio of patents that address critical health issues. Her contributions continue to impact the medical field positively.